Employees, colleagues, family and friends of Cancer Research And Biostatistics (CRAB) joined together on Sunday, November 1 to support awareness and research for pancreatic cancer. CRABCares, the CRAB public-outreach committee, participated in the 2015 PurpleStride Puget Sound event at Magnuson Park in Seattle. CRABCares members strode in this 5K fun-run/walk, sharing stories, smiles and conversation with the larger community of survivors, researchers and awareness activists.
Each year, in communities across the US, tens of thousands of people participate in more than fifty-six PurpleStride events. These events are critical in raising awareness and funds that advance research and support patients and loved ones with a promise of a better tomorrow. One of CRAB’s key research partnerships, the Pancreatic Cancer Research Team (PCRT), has member-sites across the US that participate in PurpleStride events throughout each year.
We hope you enjoyed the event!
BOSTON, July 15, 2015 – Four Beth Israel Deaconess Medical Center (BIDMC) patients who've survived pancreatic cancer were cheered alongside BIDMC’s Pancreatic Cancer Center and Project Survival in a July 10 pre-game ceremony at Fenway Park.
Recognized during the July 10 on-field ceremony were: Lindsay McGregor, NP, and James Moser, MD, representing BIDMC's Pancreatic Cancer Center; Nivin Narain, MD, CEO of Berg, representing Project Survival; and cancer survivors Mary Haskins, Paul Jodice, SusanJo Caira and Paula Mason.
The “Fenway Faithful” showed their appreciation for BIDMC’s groundbreaking cancer care during the pre-game ceremony.
Members of BIDMC’s Pancreatic Cancer Center, along with other leaders of Project Survival, an international team of cancer experts who have joined forces to cure pancreatic cancer, took the field before the Red Sox faced the New York Yankees.
The honored group included four patients who received state-of-the-art, multidisciplinary treatment at the Pancreatic Cancer Center, some of whom might not have been on the field were it not for the amazing team at BIDMC.
Fans in attendance welcomed these survivors with rousing applause as the Fenway announcer told their story. “With the help from BIDMC’s experts, they’re beating the odds – living examples of hope for thousands in their fight against pancreatic cancer,” the announcer said.
“I had the great honor of standing with fellow pancreatic cancer survivors,” said Paul Jodice. “The wonderful ovation from fans made me feel like I hit a home run.”
The Pancreatic Cancer Center is an international leader in pancreatic cancer care and research, specializing in complex pancreatic cancers and rare pancreatic conditions. Department of Surgery member James Moser, MD, Co-Director of the BIDMC Pancreas and Liver Institute, and Lindsay McGregor, NP, Nurse Coordinator, represented the Center during the ceremony.
Moser is the driving force behind Project Survival, a unique collaboration that also includes the biopharmaceutical company Berg Health, and the Pancreatic Cancer Research Team (PCRT), which is managed by Cancer Research and Biostatistics (CRAB). The unique cross-sector collaboration is leading research efforts aimed at finding a cure for pancreatic cancer by identifying diagnostic and treatment biomarkers for the disease. In addition to Moser, other representatives of Project Survival attending the ceremony were Niven Narain, PhD, president and co-founder of Berg; Amy Stoll-D’Astice, MS, CCRP, of PCRT; Ramesh Ramanathan, MD, PCRT leader for Project Survival; John Crowley, PhD, CRAB founder; and Gamze Ayata, MD, lead pathologist for Project Survival and a surgical pathologist at BIDMC.
According to the National Cancer Institute, nearly 49,000 Americans were diagnosed with pancreatic cancer in 2014, a disease from which only 6.7 percent will survive five years. “Pancreatic cancer will become the second leading cause of cancer deaths in the United States within five years, surpassing both breast and colon cancer,” Moser said in a media announcement issued in April to announce the Project Survival collaboration.
“Finding a biomarker will bring real hope to patients with pancreatic cancer,” said Moser. “We believe that Project Survival will develop the precision medicine needed to beat this terrible disease.”
Pictured above (l-r): Gamze Ayata, MD; Niven Narain, PhD; Amy Stoll-D’Astice, MS, CCRP; James Moser, MD; John Crowley, PhD; and Ramesh Ramanathan, MD
SEATTLE, June 18, 2015 – Cancer Research And Biostatistics (CRAB) is working through our Pancreatic Cancer Research Team (PCRT) network on "Project Survival," a multi-institutional collaboration targeted at pancreatic cancer to discover breakthrough diagnostics and allow for development of targeted treatments against pancreatic cancer. CRAB and the PCRT network provide the essential infrastructure and expertise for a project with these lofty goals. You can view an interview with Niven Narain, CEO of Berg, with Diedre Bolton of Fox Business on her Risk & Reward show at this link: https://youtu.be/FhnTsgJK9W8.
More information about the project can be found here: http://bit.ly/1GSJwA5.
If you are interested in supporting cancer research please consider a donation to CRAB, a 5013c non-profit research institute. Click here to donate: http://www.crab.org/Donate.aspx
Niven R. Narain, Co-Founder, President and Chief Technology Officer of Berg discusses Berg's partnership on Pancreatic Cancer, Project Survival, that could lead to a breakthrough diagnosis and treatment for the disease. Fox Business - Project Survival
CRAB had a great showing as the 2015 ASCO conference including meetings for both the Pancreatic and Lung Cancer Research Teams. The Pancreatic Cancer Research Team (PCRT) investigator meeting included more than 40 participants from around the world, six company presentations and an update from the Pancreatic Cancer Action Network (PanCAN). The keynote speaker, Dr. David Cummings, invigorated the group with thoughts of gastric bypass surgery and its potential impact on, especially diabetes, but also reducing the incidence of pancreatic cancer or cardiovascular disease. The Lung Cancer Research Team (LCRT) also had four companies present to more than 15 participants with elections for both consortia resulting in New Chairpersons: for the PCRT, Dr. Tom Dragovich as Chairman and Dr. Gabriella Chiorean as Vice Chairman. For the LCRT, Dr. Rachel Sanborn as Chairman.
Drs. Hoering and Crowley participated in key meetings at the conference including the NCI Myeloma Steering committee for the SWOG cooperative group, and the Sarcoma Alliance for Research and Collaboration. In addition, CRAB held meetings with more than twelve companies to discuss participation in critical clinical trials and partnership opportunities.
CRAB attendees at the ASCO 2015 conference were Dr. Antje Hoering, CEO; Dr. John Crowley, Chief of Strategic Alliances, Tammy Buist, Chief Business Development Officer, Dr. Lynn Shemanski, Senior Biostatistician and Amy Stoll-D’Astice, the Program Manager for the LCRT and PCRT programs.